| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 11/08/2001 | CA2407129A1 Medicinal formulation comprising pioglitazone |
| 11/08/2001 | CA2406823A1 Amphiphilic macrocyclic derivatives and their analogues |
| 11/08/2001 | CA2406755A1 A gene therapy system and method using alpha-msh and its derivatives |
| 11/08/2001 | CA2378001A1 Preparation for nasal absorption of insulin |
| 11/08/2001 | CA2377880A1 Eutectic mixtures in cosmetic compositions |
| 11/08/2001 | CA2346616A1 Stabilized protein preparation and process for its preparation |
| 11/07/2001 | EP1152026A1 Polysaccharide material for direct compression |
| 11/07/2001 | EP1152023A1 Inverse latex based on white mineral oils, squalane or hydrogenated polyisobutene, cosmetic compositions, dermocosmetics, dermopharmaceuticals or pharmaceutical compositions containing them |
| 11/07/2001 | EP1152022A1 Inverse latex based on white mineral oils, squalane, hydrogenated polyisobutene, isohexadecane or isododecane, cosmetic compositions, dermocosmetics, dermopharmaceuticals or pharmaceutical compositions containing them |
| 11/07/2001 | EP1151756A1 Application of polyacrylamide gel for forming a capsule in the tissue of a mammal organism, method for cultivating cells and method for therapy of oncological diseases and the diabetes mellitus |
| 11/07/2001 | EP1151755A1 Pharmaceutical compositions comprising cyclosporin as active ingredient |
| 11/07/2001 | EP1151750A1 Medicinal compositions retarded in the discoloration of phenolic hydroxyl compounds |
| 11/07/2001 | EP1151749A1 Sheet-form adhesive preparation |
| 11/07/2001 | EP1151746A1 Microcapsules for sustained release of drugs |
| 11/07/2001 | EP1151741A1 Microcapsules with an aqueous core containing at least an active water-soluble cosmetic or dermatologic ingredient and cosmetic or dermatologic compositions containing these microcapsules |
| 11/07/2001 | EP1151099A1 Hormone-hormone receptor complexes and nucleic acid constructs and their use in gene therapy |
| 11/07/2001 | EP1151095A1 Polypeptide variants with raised heparin-binding capacity |
| 11/07/2001 | EP1151083A1 Nitroreductase enzymes |
| 11/07/2001 | EP1151000A2 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor |
| 11/07/2001 | EP1150995A1 A synthetic peptide disturbing intracellular signaling |
| 11/07/2001 | EP1150959A1 Solid-state form of celecoxib having enhanced bioavailability |
| 11/07/2001 | EP1150820A1 Injection molding method for neutral and acidic-group containing (meth)acrylate copolymers |
| 11/07/2001 | EP1150718A1 Conjugates of lipids and antimicrobial or antineoplastic drugs |
| 11/07/2001 | EP1150717A1 Sustained release salts of pharmaceutically active peptides and their production |
| 11/07/2001 | EP1150716A1 Pharmaceutical composition of hydrophobically modified hedgehog proteins and their use |
| 11/07/2001 | EP1150712A2 Human papilloma virus vaccine formulations |
| 11/07/2001 | EP1150708A2 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules |
| 11/07/2001 | EP1150707A1 USE OF AN OmpA ENTEROBACTERIUM PROTEIN ASSOCIATED WITH THE ELAGIGILTV PEPTIDE FOR TREATING MELANOMAS |
| 11/07/2001 | EP1150706A1 Use of an enterobacterium protein ompa associated with an antigen for generating an antiviral, antiparasitic or antitumoral cytotoxic response |
| 11/07/2001 | EP1150701A2 Homing pro-apoptotic conjugates and methods of using same |
| 11/07/2001 | EP1150686A1 Directly compressible matrix for controlled release of single daily doses of clarithromycin |
| 11/07/2001 | EP1150685A1 Phosphocholine surfactants and their use |
| 11/07/2001 | EP1150675A1 A transdermal composition of an antivomiting agent and a preparation containing the same |
| 11/07/2001 | EP1150668A1 New utilization of alpha-hidroxy-propionic acid in medicine |
| 11/07/2001 | EP1150663A2 Method for producing film-type dosage forms |
| 11/07/2001 | EP1150661A2 Topical sprays comprising a film forming composition |
| 11/07/2001 | EP1150660A1 Pharmaceutical effervescent formulation containing metamizol |
| 11/07/2001 | EP1150658A2 Method for controlling liposome size |
| 11/07/2001 | EP1150655A1 Use of nanoscale chitosanes and/or chitosane derivatives |
| 11/07/2001 | EP1150643A2 Microemulsion containing alkano lammonium salts of fatty alcohol sulfates and/or alkylpoly alkylene glykol ether sulfates |
| 11/07/2001 | EP1150630A1 Prolonged release bioadhesive vaginal gel dosage form |
| 11/07/2001 | EP1150577A1 Improved microbial preparations |
| 11/07/2001 | EP1150569A1 Method for reducing hip joint laxity |
| 11/07/2001 | EP1003711B1 Novel lipopolyamines, and the preparation and use thereof |
| 11/07/2001 | EP0921812B1 Insulin preparations containing a halogenide |
| 11/07/2001 | EP0836475B1 Controlled release formulations for poorly soluble drugs |
| 11/07/2001 | EP0833609B1 Compositions and methods for stabilizing polymers |
| 11/07/2001 | EP0825865B1 Transdermal therapeutic system for administering testosterone |
| 11/07/2001 | EP0776195B1 Drug delivery composition containing chitosan or derivative thereof having a defined z. potential |
| 11/07/2001 | EP0751789B1 Gel for treatment of skin diseases and for disinfection of the skin |
| 11/07/2001 | EP0731705B1 Use of dimeticone for treating constipation |
| 11/07/2001 | EP0725628B1 Thermally-gelling drug delivery vehicles containing cellulose ethers |
| 11/07/2001 | EP0689456B1 Cosmetic compositions |
| 11/07/2001 | EP0659072B1 Pharmaceutical emulsions containing bioactive steroids |
| 11/07/2001 | EP0636033B1 Process for producing active agent complexes |
| 11/07/2001 | EP0627899B1 Injectable ceramic compositions and methods for their preparation and use |
| 11/07/2001 | CN1321092A Thermosensitive biodegradable hydrogels for sustained delivery of biologically active agents |
| 11/07/2001 | CN1321089A Methods and compositions for increasing intestinal absorption of fats |
| 11/07/2001 | CN1321088A sustained release ranolazine formulations |
| 11/07/2001 | CN1321086A Mucosal originated drug delivery system and animal applications |
| 11/07/2001 | CN1321085A Enteric and colonic delivery using HPMC capsules |
| 11/07/2001 | CN1321084A Pharmaceutical compositions comprising ibuprofen and domperidone |
| 11/07/2001 | CN1321083A Method for making coated gabapentine or pregabaline particles |
| 11/07/2001 | CN1321082A Micronised pharmaceutical compositions |
| 11/07/2001 | CN1321080A Fast dissolving orally consumable films |
| 11/06/2001 | US6313201 Modified catalase, a composition thereof and process for preparing the catalase |
| 11/06/2001 | US6313103 Pectic substance as a growth factor stabilizer |
| 11/06/2001 | US6313102 Stabilized dry composition comprising therapeutic agent susceptible to maillard reaction, further comprising reducing carbohydrate as stabilizer for therapeutic agent and inhibitor of maillard reaction |
| 11/06/2001 | US6313085 High-concentration flowable anionic surfactant mixtures containing alkyl ether sulfates and alkyl sulfates |
| 11/06/2001 | US6312939 Cells; for use in treatment of tumors, lung, breast and colon cancer and the treatment of preferential viral diseases |
| 11/06/2001 | US6312753 Cocoa components, edible products having enriched polyphenol content, methods of making same and medical uses |
| 11/06/2001 | US6312734 Forming an oxidized glutatione complex with platinum or palladium |
| 11/06/2001 | US6312732 Biodegradable targetable microparticle delivery system |
| 11/06/2001 | US6312730 Gum acacia, mixing powdered psyllium husks and drying |
| 11/06/2001 | US6312728 Drug delivery device with core, enteric polymer and coating |
| 11/06/2001 | US6312727 Delivery of nucleic acid materials |
| 11/06/2001 | US6312723 Compounds used in inhibiting gastric acid secretion 6-methoxy-2-(((4-methoxy-3, 5-dimethyl-2-pyridinyl)methyl)sulfinyl)-1h-benzimidazole in tablet or capsule form with cyclodextrin |
| 11/06/2001 | US6312721 Drugs with carriers of esters of triglycerol with fatty acid and partial esters of decaglycerol and fatty acids |
| 11/06/2001 | US6312720 Liposomal recombinant human superoxide-dismutase for the treatment of peyronie's disease |
| 11/06/2001 | US6312716 Patch and method for transdermal delivery of bupropion base |
| 11/06/2001 | US6312715 Adhesive microsphere drug delivery composition |
| 11/06/2001 | US6312712 Benzimidazole and cyclodextrin for gastric acid related diseases |
| 11/06/2001 | US6312708 Botulinum toxin implant |
| 11/06/2001 | US6312705 Complexes of iodine with nylon |
| 11/06/2001 | US6312703 Drugs or cosmetics, liquid crystal solids and lecithin |
| 11/06/2001 | US6312694 Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
| 11/06/2001 | US6312681 Compositions and methods for the treatment of cancer using recombinant viral vector delivery systems |
| 11/06/2001 | US6312679 Dense star polymer conjugates as dyes |
| 11/06/2001 | US6312665 Aerosol formulations for buccal and pulmonary application |
| 11/06/2001 | CA2250251C Pharmaceutical compositions of botulinum toxin or botulinum neurotoxin and methods of preparation |
| 11/06/2001 | CA1341315C Targeted forms of methyltrithio antitumor agents |
| 11/01/2001 | WO2001081516A1 Oil-containing granular composition and method for producing the same |
| 11/01/2001 | WO2001081426A2 Rgd (arg-gly-asp) coupled to (neuro)peptides |
| 11/01/2001 | WO2001081415A2 Parathyroid hormone and parathyroid hormone-related protein antagonists |
| 11/01/2001 | WO2001081405A2 Methods and compositions for the prevention and treatment of anemia |
| 11/01/2001 | WO2001081358A1 The use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals |
| 11/01/2001 | WO2001081355A1 Combretastatin a-1 phosphate and combretastatin b-1 phosphate prodrugs |
| 11/01/2001 | WO2001081182A2 Improved method and apparatus for generating an aerosol |
| 11/01/2001 | WO2001080920A2 Antimicrobial bioabsorbable materials |
| 11/01/2001 | WO2001080910A1 Coloured ophthalmic product |